Cardiac dysfunction is correlated with detrimental prognosis of
sepsis and contributes to a high risk of mortality. After an initial hyperinflammatory reaction, most patients enter a protracted state of immunosuppression (late
sepsis) that alters both innate and adaptive immunity. The changes of cardiac function in late
sepsis are not yet known. MicroRNA-155 (miR-155) is previously found to play important roles in both regulations of immune activation and cardiac function. In this study, C57BL/6 mice were operated to develop into early and late
sepsis phases, and miR-155 mimic was injected through the tail vein 48 h after cecal
ligation and
puncture (CLP). The effect of miR-155 on CLP-induced cardiac dysfunction was explored in late
sepsis. We found that increased expression of miR-155 in the myocardium protected against cardiac dysfunction in late
sepsis evidenced by attenuating
sepsis-reduced cardiac output and enhancing left ventricular systolic function. We also observed that miR-155 markedly reduced the infiltration of macrophages and neutrophils into the myocardium and attenuated the inflammatory response via suppression of JNK signaling pathway. Moreover, overexpression of β-
arrestin 2 (Arrb2) exacerbated the mice mortality and immunosuppression in late
sepsis. Furthermore, transfection of miR-155 mimic reduced Arrb2 expression, and then restored immunocompetence and improved survival in late septic mice. We conclude that increased miR-155 expression through systemic administration of miR-155 mimic attenuates cardiac dysfunction and improves late
sepsis survival by targeting JNK associated inflammatory signaling and Arrb2 mediated immunosuppression.